Indevus Pharmaceuticals, Inc.

33 Hayden Avenue,
Lexington, Massachusetts 02421
United States,
(781) 861-8444
www.indevus.com

Indevus Pharmaceuticals, Inc., is a biopharmaceutical company. Our products target a variety of disease areas including overactive bladder, anxiety/panic disorder, stroke, HIV/AIDS, pain and inflammation, serious fungal infections and premenstrual dysphoric disorder (PMDD).

Indevus Pharmaceuticals was acquired by Endo International on January 05, 2009.

Join Mergr to view all 110 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 97 by strategics.

Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.

Join Mergr to view this profile - and discover more life science acquisitions of companies like Indevus Pharmaceuticals.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.3K Private Equity Firms
  • 111K M&A Transactions
  • 121K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.